Cost effectiveness of personalized treatment in women with early breast cancer: the application of OncotypeDX and Adjuvant! Online to guide adjuvant chemotherapy in Austria

A Breast Cancer Outcomes model was developed at the ONCOTYROL research center to evaluate personalized test-treatment strategies in Austria. The goal was to evaluate the cost-effectiveness of a new 21-gene assay (ODX) when used in conjunction with the Adjuvant! Online (AO) decision aid to support pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Jahn, B., Rochau, U., Kurzthaler, C., Hubalek, M., Miksad, R., Sroczynski, G., Paulden, M., Kluibenschädl, M., Krahn, M., Siebert, U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666888/
https://www.ncbi.nlm.nih.gov/pubmed/26693110
http://dx.doi.org/10.1186/s40064-015-1440-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666888/
https://www.ncbi.nlm.nih.gov/pubmed/26693110
http://dx.doi.org/10.1186/s40064-015-1440-6

Ejemplares similares